Relmada Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.

CEO

Sergio Traversa

CEOSergio Traversa

Employees

Employees10

Headquarters

Coral Gables, Florida

HeadquartersCoral Gables, Florida

Founded

2012

Founded2012

Employees

Employees10

RLMD Key Statistics

Market cap

138.91M

Market cap138.91M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

581.70K

Average volume581.70K

High today

$4.77

High today$4.77

Low today

$4.54

Low today$4.54

Open price

$4.54

Open price$4.54

Volume

99.27K

Volume99.27K

52 Week high

$38.68

52 Week high$38.68

52 Week low

$4.50

52 Week low$4.50

Analyst ratings

71%

of 7 ratings

Buy

28.6%

Hold

71.4%

Sell

RLMD Earnings

-$2.44

-$1.63

-$0.81

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 22, After Hours

ActualExpected Mar 22, After Hours